Stay updated on Nivolumab in AML Remission at High Risk Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in AML Remission at High Risk Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in AML Remission at High Risk Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Adds a new page revision tag v3.5.4 and removes v3.5.3, signaling a rebuild/update of the page's version rather than a change to the study data.
    Difference
    0.1%
    Check dated 2026-05-15T11:38:24.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Updates the displayed site revision/version indicator from **v3.5.2** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-24T06:29:08.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:47:27.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and deleted Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:33:23.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    - Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:51:49.000Z thumbnail image
  9. Check
    106 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and older revision notices (v3.4.1) were removed, along with a government funding status notice; these are site housekeeping changes that do not alter the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T11:47:51.000Z thumbnail image

Stay in the know with updates to Nivolumab in AML Remission at High Risk Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in AML Remission at High Risk Clinical Trial page.